Systematic review / meta-analysis / 2020
A review of clinical trials found ginseng was mainly tested in small single-center studies, with 79.8% of published articles reporting positive effects.
Researchers systematically reviewed the characteristics of 152 registered and 119 published Panax ginseng clinical trials retrieved from major databases and trial registries. Ginseng was predominantly evaluated in single-center trials with fewer than 200 subjects and treatment durations under 3 months in healthy individuals or patients with conditions including cardiovascular and metabolic diseases. Among the 119 published trials, 95 (79.8%) reported plenty of positive effects for ginseng.
- Study type
- Systematic review of registered and published clinical trials
- Who was studied
- 152 registered and 119 published ginseng clinical trials in healthy subjects and patients with conditions like cardiovascular and metabolic diseases
- What was measured
- Clinical characteristics (duration, sample size, primary purpose, conditions, outcomes) and reported effects of ginseng
THE PAPER
Panax ginseng clinical trials: Current status and future perspectives.
Fan S, Zhang Z, Su H, Xu P, Qi H, Zhao D, Li X. Biomed Pharmacother, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.